HKEX: 2325 - Yunkang Group Limited

Yield per half year: -36.84%
Dividend yield: +0.24%
Sector: Healthcare

Yunkang Group Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
7/10
16.91 35.42 -52.25% -28 -160.38%
P/S 7.15 7.59 -5.72%
P/BV 3.01 3.68 -18.36%
P/FCF 27.61 55.38 -50.14%
Ev/Ebitda 10.99 2.91 277.94%
Ev/S 7.27 23.72 -69.35%
Ev/FCF 23.86 63.78 -62.59%
E/P -0.0136 0.0326 -141.7%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
10/10
64.06 -13.64 -569.56% 64.06 0%
ROE -4.4 5.19 -184.9%
ROA -2.17 3.47 -162.45%
ROIC 0 0 0%
ROS -11.47 -11.49 -0.1469%
ROCE 0 0.2627 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
8/10
1.38 0.7755 77.5% 1.38 0%
Nеt Debt/Ebitda 0.1816 0.0127 1324.83%
Debt/Ratio 0.1735 0.1229 41.19%
Debt/Equity 1.22 0.8005 52.99%
Debt/Net Income -7.69 1.76 -537.39%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0.6/10
0.2415 5.7 -95.76% 1.1 -77.95%
Number of years of dividend growth 2 1.13 77.78%
DSI 0.875 0.5838 49.88%
Average dividend growth -220 3.2 -6968.67%
Average percentage for 5 years 1.1 4.95 -77.89%
Average percentage for payments 12.69 23.96 -47.02%
Difference from average difference in sector -5.46

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
31.52 21.26 48.26%
Growth impulse Ebitda in 5 years 0 -43.94 -100%
Growth impulse Net Income in 5 years 230.33 83.64 175.38%
Growth impulse FCF in 5 years -447.59 79.76 -661.17%
Growth impulse EPS in 5 years 234.06 -117.1 -299.88%
IP Score
4.68/10

Similar companies

JD Health International Inc.

WuXi Biologics (Cayman) Inc.

Sinopharm Group Co. Ltd.

Hangzhou Tigermed Consulting Co., Ltd

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription